Cite
MLA Citation
Kathleen Mullin et al.. “Potential for treatment benefit of small molecule CGRP receptor antagonist plus monoclonal antibody in migraine therapy.” Neurology, vol. 94, 2020, p. . http://access.bl.uk/ark:/81055/vdc_100141227796.0x000058